Exome-Asset-Management

AI_NATIVE detailed information: This accession holds the following tickers:[
  "AKRO",
  "EWTX",
  "TRVI",
  "CNTA",
  "NKTR",
  "RGNX",
  "ARVN",
  "ANAB",
  "GPCR",
  "SVRA",
  "TVTX",
  "NUVB",
  "REPL",
  "SNDX",
  "ALVO",
  "AKBA",
  "APRE",
  "AZN",
  "ESTA",
  "GERN",
  "SRRK",
  "FULC",
  "ISRG",
  "GH",
  null,
  null,
  null,
  "IONS",
  null,
  null,
  "GEHC",
  null,
  null,
  null,
  null,
  null,
  "MBX",
  "SLNO",
  "COGT",
  "ETNB",
  "DYN",
  "GOSS",
  "PEN",
  "NTRA",
  "ELDN",
  "IMNM",
  null,
  "VRDN",
  "VYNE",
  "BHVN",
  "RDY",
  null,
  "BCRX",
  "BBIO",
  "CRBP",
  "CRNX",
  "CYTK",
  "IRON",
  "LLY"
]

Filing Details

13F-HR/A • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-16
Total Holdings: 59
Total Value: 112495086
Accession Number: 0001420506-25-001316
Form Type: 13F-HR/A
CIK: exome-asset-management
Manager Name: Exome-Asset-Management

Data Enrichment

80% identified

47 identified12 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

59 positions • $112.5M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 3 of 3

Sort by:

Biohaven Ltd.

BHVN|G1110E107

Shares:39.9K

Value:$959.2K

% of Portfolio:0.9% ($959.2K/$112.5M)

Alvotech

ALVO|L01800108

Shares:90.1K

Value:$871.3K

% of Portfolio:0.8% ($871.3K/$112.5M)

VYNE Therapeutics Inc.

VYNE|92941V308

Shares:462.8K

Value:$731.2K

% of Portfolio:0.7% ($731.2K/$112.5M)

ESTABLISHMENT LABS HOLDINGS INC.

ESTA|G31249108

Shares:13.1K

Value:$534.5K

% of Portfolio:0.5% ($534.5K/$112.5M)

BIOCRYST PHARMACEUTICALS INC

BCRX|09058V103

Shares:60.6K

Value:$454.5K

% of Portfolio:0.4% ($454.5K/$112.5M)

Eledon Pharmaceuticals, Inc.

ELDN|28617K101

Shares:114.1K

Value:$387.0K

% of Portfolio:0.3% ($387.0K/$112.5M)

Akebia Therapeutics, Inc.

AKBA|00972D105

Shares:189.1K

Value:$363.0K

% of Portfolio:0.3% ($363.0K/$112.5M)

89422G907

Shares:110.0K

Value:$231.0K

% of Portfolio:0.2% ($231.0K/$112.5M)

01438T956

Shares:100.0K

Value:$190.0K

% of Portfolio:0.2% ($190.0K/$112.5M)

Nuvation Bio Inc.

NUVB|67080N101

Shares:96.3K

Value:$169.5K

% of Portfolio:0.2% ($169.5K/$112.5M)

23282W955

Shares:23.0K

Value:$141.4K

% of Portfolio:0.1% ($141.4K/$112.5M)

85205L907

Shares:37.5K

Value:$129.4K

% of Portfolio:0.1% ($129.4K/$112.5M)

76243J955

Shares:40.0K

Value:$70.0K

% of Portfolio:0.1% ($70.0K/$112.5M)

Aprea Therapeutics, Inc.

APRE|03836J201

Shares:29.0K

Value:$59.1K

% of Portfolio:0.1% ($59.1K/$112.5M)

38341P902

Shares:100.0K

Value:$47.5K

% of Portfolio:0.0% ($47.5K/$112.5M)

640268908

Shares:75.0K

Value:$22.5K

% of Portfolio:0.0% ($22.5K/$112.5M)

G76279951

Shares:75.3K

Value:$15.1K

% of Portfolio:0.0% ($15.1K/$112.5M)

92536C903

Shares:60.0K

Value:$900

% of Portfolio:0.0% ($900/$112.5M)

834203959

Shares:11.0K

Value:$275

% of Portfolio:0.0% ($275/$112.5M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Biohaven Ltd.(BHVNcusipG1110E107)	39.9K	QoQ +41.69% (-11.7K) YoY NEW(+39.9K)	All Managers (Combined)	$959.2K	0.9% ($959.2K/$112.5M)	QoQ -8.79% (-$92.5K) YoY NEW(+$959.2K)
Alvotech(ALVOcusipL01800108)	90.1K	QoQ 0.00% (-0) YoY NEW(+90.1K)	All Managers (Combined)	$871.3K	0.8% ($871.3K/$112.5M)	QoQ -26.90% (-$320.8K) YoY NEW(+$871.3K)
VYNE Therapeutics Inc.(VYNEcusip92941V308)	462.8K	QoQ +30.94% (-109.4K) YoY +11.40% (-47.4K)	All Managers (Combined)	$731.2K	0.7% ($731.2K/$112.5M)	QoQ -38.24% (-$452.8K) YoY -42.66% (-$544.2K)
ESTABLISHMENT LABS HOLDINGS INC.(ESTAcusipG31249108)	13.1K	QoQ 0.00% (-0) YoY NEW(+13.1K)	All Managers (Combined)	$534.5K	0.5% ($534.5K/$112.5M)	QoQ -11.42% (-$69.0K) YoY NEW(+$534.5K)
BIOCRYST PHARMACEUTICALS INC(BCRXcusip09058V103)	60.6K	QoQ NEW(+60.6K) YoY NEW(+60.6K)	All Managers (Combined)	$454.5K	0.4% ($454.5K/$112.5M)	QoQ NEW(+$454.5K) YoY NEW(+$454.5K)
Eledon Pharmaceuticals, Inc.(ELDNcusip28617K101)	114.1K	QoQ -55.47% (-142.2K) YoY NEW(+114.1K)	All Managers (Combined)	$387.0K	0.3% ($387.0K/$112.5M)	QoQ -63.36% (-$669.3K) YoY NEW(+$387.0K)
Akebia Therapeutics, Inc.(AKBAcusip00972D105)	189.1K	QoQ -8.19% (-16.9K) YoY NEW(+189.1K)	All Managers (Combined)	$363.0K	0.3% ($363.0K/$112.5M)	QoQ -7.22% (-$28.3K) YoY NEW(+$363.0K)
(cusip89422G907)✕	110.0K	QoQ NEW(+110.0K) YoY NEW(+110.0K)	All Managers (Combined)	$231.0K	0.2% ($231.0K/$112.5M)	QoQ NEW(+$231.0K) YoY NEW(+$231.0K)
(cusip01438T956)✕	100.0K	QoQ NEW(+100.0K) YoY NEW(+100.0K)	All Managers (Combined)	$190.0K	0.2% ($190.0K/$112.5M)	QoQ NEW(+$190.0K) YoY NEW(+$190.0K)
Nuvation Bio Inc.(NUVBcusip67080N101)	96.3K	QoQ NEW(+96.3K) YoY NEW(+96.3K)	All Managers (Combined)	$169.5K	0.2% ($169.5K/$112.5M)	QoQ NEW(+$169.5K) YoY NEW(+$169.5K)
(cusip23282W955)✕	23.0K	QoQ NEW(+23.0K) YoY NEW(+23.0K)	All Managers (Combined)	$141.4K	0.1% ($141.4K/$112.5M)	QoQ NEW(+$141.4K) YoY NEW(+$141.4K)
(cusip85205L907)✕	37.5K	QoQ NEW(+37.5K) YoY NEW(+37.5K)	All Managers (Combined)	$129.4K	0.1% ($129.4K/$112.5M)	QoQ NEW(+$129.4K) YoY NEW(+$129.4K)
(cusip76243J955)✕	40.0K	QoQ NEW(+40.0K) YoY NEW(+40.0K)	All Managers (Combined)	$70.0K	0.1% ($70.0K/$112.5M)	QoQ NEW(+$70.0K) YoY NEW(+$70.0K)
Aprea Therapeutics, Inc.(APREcusip03836J201)	29.0K	QoQ -77.35% (-99.0K) YoY NEW(+29.0K)	All Managers (Combined)	$59.1K	0.1% ($59.1K/$112.5M)	QoQ -85.91% (-$360.6K) YoY NEW(+$59.1K)
(cusip38341P902)✕	100.0K	QoQ NEW(+100.0K) YoY NEW(+100.0K)	All Managers (Combined)	$47.5K	0.0% ($47.5K/$112.5M)	QoQ NEW(+$47.5K) YoY NEW(+$47.5K)
(cusip640268908)✕	75.0K	QoQ NEW(+75.0K) YoY NEW(+75.0K)	All Managers (Combined)	$22.5K	0.0% ($22.5K/$112.5M)	QoQ NEW(+$22.5K) YoY NEW(+$22.5K)
(cusipG76279951)✕	75.3K	QoQ NEW(+75.3K) YoY NEW(+75.3K)	All Managers (Combined)	$15.1K	0.0% ($15.1K/$112.5M)	QoQ NEW(+$15.1K) YoY NEW(+$15.1K)
(cusip92536C903)✕	60.0K	QoQ NEW(+60.0K) YoY NEW(+60.0K)	All Managers (Combined)	$900	0.0% ($900/$112.5M)	QoQ NEW(+$900) YoY NEW(+$900)
(cusip834203959)✕	11.0K	QoQ NEW(+11.0K) YoY NEW(+11.0K)	All Managers (Combined)	$275	0.0% ($275/$112.5M)	QoQ NEW(+$275) YoY NEW(+$275)